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i n d i a n h e a r t j o u r n a l 6 4 ( 2 0 1 2 ) 6 2 4e6 2 7626PAPP-A with that of a cardiospecific troponin assay were
considered eligible for meta-analysis. Potential discrepancies
between authors were solved by CM.
Five studies, totalling 2050 patients (1333 cases and 717
controls), met our inclusion criteria (I-squared heterogeneity,
82%).1,3e6 Interestingly, the cumulativeAUC for troponin alone
was marginally but still significantly higher (0.85; 95% CI,
0.78e0.92) than that of PAPP-A alone (0.67; 95% CI, 0.54e0.80;
p ¼ 0.03) (Fig. 1). Pooled data about sensitivity and specificity
could not be calculated, since these were not provided in all
studies. In the only one study comparing troponin alone with
the combination of troponin and PAPP-A, the AUC obtained
with the two biomarker approach was marginally but not
significantly improved (i.e., 0.955 versus 0.952; p ¼ 0.42).6
Taken together, the results of this meta-analysis including
2050 patients with ischemic heart disease suggest that PAPP-A
may not be useful in the early diagnosis of AMI as a stand
alone test, whereas further studies should be planned to
establish its diagnostic accuracy in combination with a car-
diospecific troponin immunoassay.r e f e r e n c e s
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To the Editor,
We have read with interest the letter written by Dr. Giuseppe
Lippi about our article on “Pregnancy-associated plasma
proteinA (PAPP-A)”. Dr. Lippi has concluded that PAPP-A alone
cannot be used as amarker for diagnosis of acuteMI and it has
to be used in combination with tropnin and we have also
concluded the same. Area Under the time concentration
Curve (AUC) for discrimination between ischemic and non-ischemic subsets improved only when PAPP-A was used in
combination with tropnin and CK-MB.
Prema Gurumurthy
Director e Academics, FLL Hospital and
Dr K M Cherian Heart Foundation, India
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generator destructive-replacement for lead-pin/lead-port clip
aperture misalignment
Medtronic introduced low-cost Champion VVI pacing devices
for use in countries such as India a few years ago and were
subsequently withdrawn. These devices are still being
encountered when patients with devices present themselves
for battery replacement. Figures 1 and 2 show the method of
finger pressure application over the implantable pulse
generator (IPG) header in order to align the pair of apertures
for correct lead-pin insertion or removal and Figure 3 depictsa correctly engaged lead-pin. Although very simple in design
we describe a problem faced at pacemaker IPG replacement
due to lead-pin misalignment in the lead-port.
A 52-year-old patient implanted with such a VVI pace-
maker (Model no, 8079, SN PGE005827C) in 2003 was found to
have a stuck lead-pin in the IPG lead-port due to misalign-
ment with the second (deeper) of the two holes present in
the self-retaining spring clip of the lead-port at IPG
